1.
Blood Cancer J
; 13(1): 150, 2023 09 26.
Artículo
en Inglés
| MEDLINE
| ID: mdl-37752126
Asunto(s)
Leucemia-Linfoma Linfoblástico de Células Precursoras , Niño , Humanos , Lactante , Australia/epidemiología , Nueva Zelanda/epidemiología , Progresión de la Enfermedad , Leucemia-Linfoma Linfoblástico de Células Precursoras/epidemiología , Leucemia-Linfoma Linfoblástico de Células Precursoras/terapia , Sobrevivientes
2.
J Pediatr Hematol Oncol
; 41(8): 620-623, 2019 11.
Artículo
en Inglés
| MEDLINE
| ID: mdl-29889804
RESUMEN
In this report, we present a young infant with multisystem Langerhans cell histiocytosis, who after cladribine and cytarabine salvage treatment developed immune thrombocytopenia (IT). On review of the literature, there were no previous reports of Langerhans cell histiocytosis-associated IT. Treatment of the IT with intravenous immunoglobulin and oral corticosteroids was unsuccessful. Eltrombopag, in combination with a 4-day course of dexamethasone was commenced as second-line therapy. Platelet recovery occurred 10 days after initiation of eltrombopag. The immune thrombocytopenia remains in long-term remission despite cessation of eltrombopag. Eltrombopag was safe and well tolerated.